| Patents for C07C 229 - Compounds containing amino and carboxyl groups bound to the same carbon skeleton (21,416) |
|---|
| 03/08/2006 | CN1244545C Production of 6-aminocaproic acid |
| 03/08/2006 | CN1244542C Aromatic amine derivatives having NOS inhibitory effect |
| 03/08/2006 | CN1244521C Site-specific isotopically-labeled proteins, amino acids, and biochemical precursors therefor |
| 03/07/2006 | US7009076 Process for recovering betaine |
| 03/07/2006 | US7009069 Intermediates for use in retinoid synthesis |
| 03/07/2006 | US7008935 novel sunscreen agents such as Dipotassium Salt of 2-(4-acetamidobenzylidene)malonic Acid or Dipiperidinium Salt of 2-(4-aminobenzylidene)malonic Acid; absorbing within the region of UV-B radiation; cosmetics; photostability, water solubility |
| 03/02/2006 | WO2005079774A3 Management of ophthalmologic disorders, including macular degeneration |
| 03/02/2006 | WO2005070869A8 Selective hydrogenation of nitrogen containing aromatics |
| 03/02/2006 | WO2004110364A3 Thiotungstate analogues and uses thereof |
| 03/02/2006 | WO2004052850A3 Methods and compounds producing dipeptidyl peptidase iv inhibitors and intermediates thereof |
| 03/02/2006 | WO2003062248A3 N-(benzyl)aminoalkylcarboxylates, phosphinates, phosphonates and tetrazoles as edg receptor agonists |
| 03/02/2006 | US20060047002 Acetalizing a 5-aminoshikimic ester, reductive ketal ring opening, replacing the 4-hydroxy group with an amine group and the 5-free amino group with a secondary or tertiary amine group, acylating the 4-amino group, and cleaving the substituents on the 5-amino group to reform the free amine group |
| 03/01/2006 | EP1628947A2 3,4-disubstituted benzamidines and benzylamines, and analogues thereof, useful as serine protease inhibitors |
| 03/01/2006 | CN1741985A Calcilytic compounds |
| 03/01/2006 | CN1741984A CaSR antagonist |
| 03/01/2006 | CN1740143A Prepn process of metal-amino acid chelate |
| 02/28/2006 | USRE38995 Interfacial method of preparing ester-substituted diaryl carbonates |
| 02/28/2006 | US7005543 Such as anhydrous betaine and betaine hydrochloride, by treating chloroacetic acid with sodium carbonate, and then dropping liquid trimethylamine, wherein ion exchange resin and decompression are used to assure high product purity and yield |
| 02/28/2006 | US7005450 2-amino-2-alkyl-4 hexenoic and hexynoic acid derivatives useful as nitric oxide synthase inhibitors |
| 02/28/2006 | US7005141 Modified amino acids and derivatives can form non-covalent mixtures with active biological agents and in an alternate embodiment can releasably carry active agents. Modified amino acids can also form drug containing microspheres. |
| 02/23/2006 | US20060041164 liver X receptor LXR agonists; increasing ABCA1, ABCG1, and apolipoprotein E expression, increasing cholesterol efflux from peripheral cells, cardiovascular disease, inflammation; 2-(3-{3-[[2-Chloro-3-(trifluoromethyl)benzyl](2,2-diphenylethyl)amino]-2-methyl-propoxy}-phenyl)acetic acid methyl ester |
| 02/23/2006 | US20060041163 Process for the production of optically active 3-phenylisoserine |
| 02/23/2006 | US20060041127 Method for the regioselective preparation of substituted benzo[g]quinoline-3-carbonitriles and benzo[g]quinazolines |
| 02/23/2006 | US20060041095 Intermediate products, methods for their preparation and use thereof |
| 02/23/2006 | US20060039962 Amphiphilic compounds and vesicles liposomes for organ-specified drug targeting |
| 02/23/2006 | DE102004039486A1 Production of organic compounds of trace elements, e.g. zinc methionate for use as animal feed additive, involves the solid-state reaction of a metal oxide and a solid organic acid in a pulveriser, e.g. a vibration grinding mill |
| 02/23/2006 | DE102004039281A1 UV Filter UV filter |
| 02/22/2006 | EP1627868A2 Aspartic ester functional compounds |
| 02/22/2006 | EP1322958B1 Selective binding materials |
| 02/22/2006 | CN1738795A Indenoncarboxylic acids derivatives and their use for the treatment of and preventing diabetes and dyslipidaemia |
| 02/22/2006 | CN1738782A Deuterated catecholamine derivatives and medicaments comprising said compounds |
| 02/22/2006 | CN1738613A Methods of using and compositions comprising (+)-3-(3,4-dimethoxy-phenyl)-3-(1-oxo-1,3-dihydro-isoindol-2-yl)-propionamide |
| 02/22/2006 | CN1243001C Method of manufacturing sertindole |
| 02/22/2006 | CN1242984C Method for synthesizing dichlofenac sodium |
| 02/21/2006 | US7002042 Cationic liposomes for gene transfer |
| 02/21/2006 | US7002038 Method for producing 3-amino-4,4,4-trifluorocrotonic acid esters |
| 02/21/2006 | US7002036 For production of (poly)peptides; comprises Michael-type addition of nucleophile to a dialkyl 2-methylidenylpropan-1,3-dioate and conversion of ester to amino moiety |
| 02/21/2006 | US7002010 Process for the preparation of morpholinones as light stabilizers |
| 02/16/2006 | WO2006016510A1 Method for producing 2-amino-5-iodobenzoic acid |
| 02/16/2006 | WO2005058798A3 Compounds having selective cytochrome p450rai-1 or selective cytochrome p450rai-2 inhibitory activity and methods of obtaining the same |
| 02/16/2006 | US20060036109 Tropylideneamines and use thereof |
| 02/16/2006 | US20060035972 Therapeutic compositions and uses |
| 02/16/2006 | US20060034773 Multidentate AZA ligands able to complex metal ions and the use thereof in diagnostics and therapy |
| 02/16/2006 | DE102004033406A1 Verfahren zur Herstellung der enantiomeren Formen von 2,3-Diaminopropionsäurederivaten A process for preparing the enantiomeric forms of 2,3-Diaminopropionsäurederivaten |
| 02/16/2006 | CA2575139A1 Diastereoselective reductive amination process |
| 02/15/2006 | CN1735589A Method for preparing 4-hydroxyisoleucine diastereoisomers and enantiomers and derivatives thereof |
| 02/15/2006 | CN1735588A Synthesis for (R) and (S)-aminocarnitine and derivatives thereof from D-and L-aspartic acid |
| 02/15/2006 | CN1733744A Process for producing benzoxazine derivative and production intermediate thereof |
| 02/15/2006 | CN1733706A Crystalline salts of dodecyl 2-(n,n-dimethylamino)-propionate |
| 02/15/2006 | CN1733705A Ethyl glycinate hydrochloride production method |
| 02/15/2006 | CN1733704A Synthesis and biological and pharmacological action of betaine salicylate |
| 02/14/2006 | CA2250850C Preparation of substituted aromatic amines |
| 02/14/2006 | CA2209825C Heterocyclic-fused pyridines |
| 02/14/2006 | CA2209131C Process for preparing mono and polyaspartates |
| 02/09/2006 | WO2005118511A3 Compounds, compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding |
| 02/09/2006 | DE102004034271A1 Wasserlösliche Aspartate Water-soluble Aspartate |
| 02/09/2006 | CA2571918A1 Process for the preparation of amino acids useful in the preparation of peptide receptor modulators |
| 02/08/2006 | EP1144348B1 Lta 4 hydrolase inhibitors |
| 02/08/2006 | CN1732002A Derivatives of aryl-quinazoline/aryl-2amino-phenyl methanone which promote the release of parathyroid hormone |
| 02/08/2006 | CN1730465A Purification and production methods of 1-aminocyclopropanecarboxylic acid |
| 02/08/2006 | CN1240672C Process for producing acidic N(long-chain acyl) amino acid |
| 02/08/2006 | CN1240671C N-(l- deoxyglucose alcoho1-1-yl) amino acid and producing process and use thereof |
| 02/08/2006 | CN1240670C Process of separating DL-alpha lactamic acid by ion membrane electric dialysis method |
| 02/07/2006 | US6995286 Process for preparing isomers of salbutamol |
| 02/07/2006 | US6995151 Isophthalic acid derivatives as matrix metalloproteinase inhibitors |
| 02/07/2006 | CA2265527C Process for the preparation of substituted aromatic amino compounds |
| 02/02/2006 | WO2006010775A1 Tyrosine derivatives as ppar-gamma-modulators |
| 02/02/2006 | WO2006010362A1 Amino adamantane derivatives, methods for the production and use thereof |
| 02/02/2006 | WO2005087692A3 Process for recovering organic compounds from aqueous streams containing same |
| 02/02/2006 | US20060025594 Small molecule entry inhibitors |
| 02/02/2006 | US20060025474 Bisphenyl compounds useful as vitamin D3 receptor agonists |
| 02/02/2006 | US20060025396 Isophthalic acid derivatives as matrix metalloproteinase inhibitors |
| 02/02/2006 | US20060024523 Organic electroluminescence device |
| 02/02/2006 | DE102004031569A1 Bulk production of storage-stable lyophilized mafosfamide lysine salt, for use as antitumor agent, by reacting another mafosfamide salt with packed ion exchange column charged with lysine and lyophilizing eluate |
| 02/02/2006 | CA2574021A1 Tyrosine derivatives as ppar-gamma-modulators |
| 02/01/2006 | EP1621529A1 3-AMINO-3-ARYLPROPIONIC ACID n-ALKYL ESTERS, PROCESS FOR PRODUCTION THEREOF, AND PROCESS FOR PRODUCTION OF OPTICALLY ACTIVE 3-AMINO-3-ARYLPROPIONIC ACIDS AND ESTERS OF THE ANTIPODES THERETO |
| 02/01/2006 | EP1620381A1 Hydroanthracene based compounds as anticancer agents |
| 02/01/2006 | EP1463707A4 A group of novel anti-cancer compounds with specific structure |
| 02/01/2006 | EP0905167B1 Diaminobenzene derivatives, polyimides prepared therefrom, and alignment film for liquid crystals |
| 02/01/2006 | CN1729157A Substituted amino phenylacetic acids, derivatives thereof, their preparation and their use as cyclooxygenase 2 (COX-2) inhibitors |
| 02/01/2006 | CN1729156A Amphiphilic star-like macromolecules for drug delivery |
| 02/01/2006 | CN1727329A New method for synthesizing Gabapentin hydrochloride |
| 02/01/2006 | CN1727328A Method for preparing L-carnitine |
| 02/01/2006 | CN1239469C Chiral amine compound and its synthesis and use |
| 02/01/2006 | CN1239441C Method for processing asymmetric hydroxylamination and dihydroxylation reaction by use of supported bi-cinchoni alkaloid ligand |
| 01/31/2006 | US6992217 Telecheolic polymers; using promoter; addition polymer |
| 01/31/2006 | US6992216 Subjecting solution of amino acid, such as L-thyroxine, to ultrasonic agitation at temperature and for period of time sufficient to produce crystalline form of amino acid having reduced particle size |
| 01/31/2006 | US6992211 Crystalline form of phenylethanolamine, the preparation thereof and pharmaceutical compositions comprising the same |
| 01/31/2006 | US6992207 Melphalan derivatives and their use as cancer chemotherapeutic drugs |
| 01/31/2006 | US6992107 (photodynamic therapy); branched alkyl and substituted benzyl ALA esters are precursors to in vitro porphyrin formation upon illumination; enhanced tumor selectivity, improved uptake, reduced pain sensation when administered; in vitro diagnosis kit |
| 01/26/2006 | WO2005105730A3 Method of preparing an alcohol from a halogenoaromatic compound and an aldehyde |
| 01/26/2006 | US20060020034 Processes for the preparation of Gabapentin |
| 01/26/2006 | US20060020028 Levodopa prodrugs, and compositions and uses thereof |
| 01/26/2006 | US20060019565 Method for delivering biologically active substnces |
| 01/26/2006 | US20060018846 Animo substituted hydroxyphenyl benzophenone derivatives |
| 01/26/2006 | CA2573128A1 Preparation of beta-amino acids having affinity for the alpha-2-delta protein |
| 01/26/2006 | CA2573109A1 Non-natural amino acids |
| 01/25/2006 | EP1619181A1 Processes for the preparation of gabapentin |
| 01/25/2006 | EP1619179A1 Production method of O-substituted tyrosine compound |
| 01/25/2006 | EP1618086A2 Compounds for the treatment of metabolic disorders |